Method for identifying type I diabetes mellitus in humans
Patent
·
OSTI ID:1016737
- Kennewick, WA
- Richland, WA
- Pasco, WA
A method and system for classifying subject populations utilizing predictive and diagnostic biomarkers for type I diabetes mellitus. The method including determining the levels of a variety of markers within the serum or plasma of a target organism and correlating this level to general populations as a screen for predisposition or progressive monitoring of disease presence or predisposition.
- Research Organization:
- Pacific Northwest National Laboratory (PNNL), Richland, WA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC05-76RLO1830
- Assignee:
- Battelle Memorial Institute (Richland, WA)
- Patent Number(s):
- 7,923,253
- Application Number:
- US Patent Application 12/291,173
- OSTI ID:
- 1016737
- Country of Publication:
- United States
- Language:
- English
Increased plasma corticosteroid-binding globulin in insulin-dependent pubertal diabetics: Relationships with other glycoproteins, growth hormone and prolactin
|
journal | October 1979 |
Salivary protein profiling in type I diabetes using two-dimensional electrophoresis and mass spectrometry
|
journal | March 2006 |
Similar Records
Serum markers for type II diabetes mellitus
MicroRNAs as biomarkers of diabetic retinopathy and disease progression
Serum biomarkers for diagnosis and prediction of type 1 diabetes
Patent
·
Tue Mar 18 00:00:00 EDT 2014
·
OSTI ID:1016737
+3 more
MicroRNAs as biomarkers of diabetic retinopathy and disease progression
Journal Article
·
Fri Nov 01 00:00:00 EDT 2019
· Neural Regeneration Research
·
OSTI ID:1016737
Serum biomarkers for diagnosis and prediction of type 1 diabetes
Journal Article
·
Thu Nov 01 00:00:00 EDT 2018
· Translational Research
·
OSTI ID:1016737